Israel’s SpliSense (see here), is developing mRNA-altering therapies for cystic fibrosis (CF) and other genetic pulmonary diseases. SpliSense founder Professor Batsheva Kerem was part of the Hebrew University team that identified the CFTR gene and developed the CF therapy.
https://www.calcalistech.com/ctech/articles/0,7340,L-3907693,00.html